FDA approves Lisraya for dermatomyositis in adults
The U.S. Food and Drug Administration has approved Lisraya (brepocitinib) tablets as the first oral treatment for dermatomyositis in adults.
14 hours ago
0
2
The U.S. Food and Drug Administration has approved Lisraya (brepocitinib) tablets as the first oral treatment for dermatomyositis in adults.
14 hours ago
0
2
New research published in the American Journal of Critical Care found that patients reported significantly lower anxiety after a short treatment session with a 15-pound (6.8-kilogram) weighted blanket. The study is unique ...
15 hours ago
0
2
A study conducted at the University of Helsinki indicates that the total number of people with dementia will grow significantly in the coming years, and the number of those living at home may even more than double after 2018.
16 hours ago
0
2
The myth that when women live together their menstrual cycles become synchronized has long persisted—despite research showing there's no evidence that this so-called McClintock effect exists. Any overlap that does happen ...
16 hours ago
0
3
Children and teens with disruptive behavior problems present major challenges to the people in their environment. But when parents seek mental health treatment for symptoms including aggression, defiance and serious rule-breaking, ...
15 hours ago
0
1
Virtual reality-based digital defocus vision training (DDVT) may be a promising adjunctive approach for pediatric myopia control, according to a study published online Aug. 27 in JAMA Ophthalmology.
15 hours ago
0
2
The Great British Bake Off offers drama, baking tips and—for one viewer in South Carolina—inspiration for creating 3D models that can be used to test cancer drugs.
10 hours ago
0
3
Every year, thousands of babies are born prematurely, interrupting critical stages of development. Researchers Giulia Palladino and Julia Meijer from Eindhoven University of Technology (TU/e) and Máxima Medical Center have ...
13 hours ago
0
1
A drug that blocks calcium release-activated calcium (CRAC) channels may help interrupt harmful immune cell interactions that drive severe viral pneumonia, according to a new study published in The Journal of Clinical Investigation. ...
17 hours ago
0
3
As a mental health nurse practitioner who sees patients both in person and via telehealth, I'm often struck by just how many of my patients would not have received any mental health treatment before the COVID-19 pandemic: ...
16 hours ago
0
1